Lots of fake stem cell treatments across the USA. There is no reason to believe the FDA would attempt to stop RCH-01, a relatively safe autologous procedure by comparison, from being sold to the public, and even before it is FDA-approved. Early market penetration would trump regulations. Everyone and his dog knows it.
Replicel has exclusive rights to rch-01 outside of Asia. Anyone attempting to produce it other than them would be liable to a pretty hefty legal challenge.
